Geron Corporation (GERN) - Latest Market Data

Price & Market Data

Price: $1.41

Daily Change: +$0.02 / 1.42%

Range: $1.36 - $1.48

Market Cap: $901,231,936

Volume: 379,642

Performance Metrics

1 Week: 13.31%

1 Month: -17.35%

3 Months: -53.48%

6 Months: -64.43%

1 Year: -62.33%

YTD: -60.31%

Company Details

Employees: 229

Sector: Health technology

Industry: Biotechnology

Country: United States

Details

Geron Corporation, a commercial-stage biopharmaceutical company, focuses on the development of therapeutics products for oncology. It offers RYTELO a telomerase inhibitor for the treatment f adult patients with low- to intermediate-1 risk myelodysplastic syndromes with transfusion-dependent anemia. The company was incorporated in 1990 and is headquartered in Foster City, California.

Selected stocks

RPC, Inc. (RES)

Aberdeen Emerging Markets Equity Income Fund, Inc. (AEF)

Everspin Technologies, Inc. (MRAM)